An In-Depth Overview of Interstitial Lung Diseases for Healthcare Professionals
OthersPage Navigation
Introduction
Interstitial Lung Diseases (ILDs) encompass over 200 pulmonary disorders, characterized by fibrotic and inflammatory changes in the lung interstitium.
Etiology and Classification
ILDs can be idiopathic, or related to systemic diseases, environmental exposure, or drugs. They're classified into four categories: idiopathic interstitial pneumonias, ILDs associated with systemic diseases, granulomatous ILDs, and other ILDs.
Clinical Presentation and Diagnosis
Patients typically present with dyspnea and dry cough. Diagnosis involves clinical evaluation, pulmonary function tests, high-resolution CT, and sometimes lung biopsy.
Treatment
Treatment varies depending on the specific ILD and its cause, but often involves corticosteroids and immunosuppressants.
Conclusion
Understanding ILDs is crucial for early detection and appropriate treatment, thereby improving patient outcomes.
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup
2.
Olaparib-Abiraterone in mCRPCs Selected by Biomarkers Outperforms Each Agent by Itself.
3.
Top 10 questions about breast cancer answered
4.
Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study
5.
For some patients with bladder cancer that has invaded the muscle, trimodality therapy is just as effective as radical cystectomy.
1.
Single-Cell Lineage Tracing in Hematology: Decoding the Cellular Blueprint of Blood Disorders
2.
Unlocking the Potential of Red Bone Marrow in the Formation of Blood Cells
3.
Cancer Vaccines in Solid Tumors: Current Landscape, Mechanisms, and Clinical Implications
4.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
5.
Intratumoral Drug Distribution as a Determinant of Therapeutic Success
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
2.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
3.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge